News
Could Kyowa Kirin be eyeing ophthalmology use for cancer dru...
Kyowa Kirin has bought back rights outside of cancer to tivozanib, amending an agreement dating back to 2006 with AVEO, and opening up the possibility of research in ophthalmology.
